A Case of Neuromyelitis Optica Spectrum Disorder Who Relapsed Under Oral Corticosteroid Treatment with Multiple Cerebrospinal Lesions and Severe Neurological Deficits-Reference-Cited by-同舟云学术

A Case of Neuromyelitis Optica Spectrum Disorder Who Relapsed Under Oral Corticosteroid Treatment with Multiple Cerebrospinal Lesions and Severe Neurological Deficits

Published:2021-06-01 Issue:2 Volume:43 Page:255-261
ISSN:0387-821X
Container-title:Journal of UOEH
language:en
Short-container-title:J UOEH

Author:

UEMOTO Yuri¹,SHIRAISHI Wataru¹²,FUJIKI Ryosuke¹,FURUTA Konosuke¹

Affiliation:

1. Department of Neurology, Kokura Memorial Hospital, Japan

2. Shiraishi Internal Medicine Clinic, Japan

Publisher

The University of Occupational and Environmental Health, Japan

Subject

Public Health, Environmental and Occupational Health,General Medicine

Link

https://www.jstage.jst.go.jp/article/juoeh/43/2/43_255/_pdf

Reference22 articles.

1. 1. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF & Weinshenker BG (2006): Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10): 1485−1489

2. 2. Wingerchuk DM, Banwell B, Bennett JL et al (2015): International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2): 177−189

3. 3. Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004): A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (9451): 2106−2112

4. 4. 渡邉充（2019）: 【さまざまな神経筋疾患を理解する】多発性硬化症と類縁疾患．ディサースリア臨床研究 9(1): 46−52

5. 5. 中島一郎（2020）: 【神経難病をクスリで治す－薬物開発の現況と近未来への展望】視神経脊髄炎スペクトラム障害治療の展望．BRAIN and NERVE: 神経研究の進歩 72(1): 61−68